康方生物授出711.5万份购股权及342万个受限制股份单位

金融界
May 26, 2025

智通财经讯,康方生物(09926)公布,于2025年5月24日,该公司根据购股权计划向114名承授人(包括董事)授出711.5万份购股权,惟须待承授人接纳后方可作实。授出的购股权行使价为每股股份84.60港元,有效期10年。其中,有408万份购股权授予董事。同日起,公司根据2021年受限制股份单位计划向107名承授人(包括董事)授出342万个受限制股份单位,惟须待承授人接纳后方可作实。其中,有...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10